Mga Batayang Estadistika
| CIK | 1050007 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to NusaTrip Incorporated
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 9, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* NUTRACEUTICAL INTL CORP (Name of Issuer) Common Stock (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| September 5, 2017 |
Nutraceutical International 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-23731 Nutraceutical International Corporation (Exact name of registrant |
|
| August 28, 2017 |
Nutraceutical International POS AM As filed with the Securities and Exchange Commission on August 28, 2017 Registration No. |
|
| August 28, 2017 |
Nutraceutical International POS AM As filed with the Securities and Exchange Commission on August 28, 2017 Registration No. |
|
| August 28, 2017 |
Nutraceutical International AW NUTRACEUTICAL INTERNATIONAL CORPORATION 1400 Kearns Boulevard, 2nd Floor Park City, Utah August 28, 2017 Via EDGAR Securities and Exchange Commission 100 F. |
|
| August 28, 2017 |
Nutraceutical International AW NUTRACEUTICAL INTERNATIONAL CORPORATION 1400 Kearns Boulevard, 2nd Floor Park City, Utah August 28, 2017 Via EDGAR Securities and Exchange Commission 100 F. |
|
| August 25, 2017 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION NUTRACEUTICAL INTERNATIONAL CORPORATION Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NUTRACEUTICAL INTERNATIONAL CORPORATION FIRST The name of the corporation is Nutraceutical International Corporation (the ?Corporation?). SECOND The address of the Corporation?s registered office in the State of Delaware is 200 Bellevue Parkway, Suite 210, in the City of Wilmington, County of New Castle, Delaware 19809. The name of i |
|
| August 25, 2017 |
EX-3.2 3 a17-209781ex3d2.htm EX-3.2 Exhibit 3.2 SECOND AMENDED AND RESTATED BY-LAWS OF NUTRACEUTICAL INTERNATIONAL CORPORATION A Delaware corporation (Adopted as of August 23, 2017) ARTICLE I OFFICES Section 1 Registered Office. The registered office of the corporation in the State of Delaware shall be located at 251 Little Falls Drive, City of Wilmington, County of New Castle, Delaware 19808. The |
|
| August 25, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 23, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| August 23, 2017 |
Nutraceutical International AMENDMENT NO. 1 S-8 POS 1 eh1700910s8pos3.htm AMENDMENT NO. 1 As filed with the Securities and Exchange Commission on August 23, 2017 Registration Nos. 333-186362 333-49885 333-49887 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-186362 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-4988 |
|
| August 23, 2017 |
Nutraceutical International AMENDMENT NO. 1 As filed with the Securities and Exchange Commission on August 23, 2017 Registration Nos. |
|
| August 23, 2017 |
Nutraceutical International AMENDMENT NO. 1 As filed with the Securities and Exchange Commission on August 23, 2017 Registration Nos. |
|
| August 23, 2017 |
Nutraceutical International AMENDMENT NO. 1 As filed with the Securities and Exchange Commission on August 23, 2017 Registration No. |
|
| August 23, 2017 |
Nutraceutical International AMENDMENT NO. 2 As filed with the Securities and Exchange Commission on August 23, 2017 Registration No. |
|
| August 21, 2017 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 21, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of Incorporation) (Commission File |
|
| August 11, 2017 |
NUTR / Nutraceutical International Corp. / Weiss Asset Management LP Passive Investment =============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| July 27, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| July 27, 2017 |
NUTRACEUTICAL REPORTS FISCAL 2017 Q3 RESULTS Exhibit EXHIBIT 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2017 Q3 RESULTS PARK CITY, Utah, July 27, 2017/PRNewswire/-Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2017 third quarter ended June 30, 2017. Net sales for the fiscal 2017 thi |
|
| July 27, 2017 |
NUTR / Nutraceutical International Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended June 30, 2017 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| July 24, 2017 |
Nutraceutical International DEFM14A DEFM14A 1 a2232756zdefm14a.htm DEFM14A Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate b |
|
| July 20, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 20, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of Incorporation) (Commission File Nu |
|
| July 20, 2017 |
Nutraceutical International 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 20, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of Incorporation) (Commission File Nu |
|
| July 12, 2017 |
Nutraceutical International PRER14A Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 12, 2017 |
Nutraceutical International ESP Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019-6064 July 12, 2017 Via EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, NE Washington, D. |
|
| June 21, 2017 |
NUTR / Nutraceutical International Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Nutraceutical International Corporation (Name of Issuer) Common stock, $0.01 par value per share (Title of Class of Securities) 67060Y101 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number o |
|
| June 20, 2017 |
Nutraceutical International PREM14A Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 9, 2017 |
8-K 1 eh17007218k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 7, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of Inco |
|
| June 9, 2017 |
Nutraceutical International FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 7, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of Incorporation) (Commission File Num |
|
| May 23, 2017 |
Form of Change in Control Protection Agreement EXHIBIT 10.1 May [], 2017 [NAME] [ADDRESS] [ADDRESS] Re: Change in Control Protection Agreement Dear [NAME]: Nutraceutical International Corporation (the “ Company”) recognizes that your continued employment and services contribute greatly to the success of the Company. In order to assure your continued services and attention to your employment duties without personal distraction in the event of a |
|
| May 23, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 22, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of Incorporation) (Commission File Num |
|
| May 22, 2017 |
Frequently Asked Questions and Answers About Announced Pending Transaction with HGGC EXHIBIT 99.2 Frequently Asked Questions and Answers About Announced Pending Transaction with HGGC Nutraceutical International Corporation and its subsidiaries (?Nutraceutical? or the ?Company?) recently announced that it entered into an Agreement and Plan of Merger (the ?Merger Agreement?) with an affiliate of HGGC, LLC (?Buyer? or ?HGGC?). This communication is intended to address certain questio |
|
| May 22, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K 1 a17-1397618k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 21, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of Incorpor |
|
| May 22, 2017 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among NUTRITION PARENT, LLC, NUTRITION SUB, INC. and NUTRACEUTICAL INTERNATIONAL CORPORATION Dated as of May 21, 2017 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS & INTERPRETATIONS 2 1.1 Certain Definitions 2 1.2 Additional Definitions 14 1.3 Certain Interpretations 16 ARTICLE II THE MERGER 17 2.1 The Merger 17 2.2 The Effective Time 18 2.3 The Closi |
|
| May 22, 2017 |
NUTRACEUTICAL ENTERS INTO A DEFINITIVE AGREEMENT TO BE ACQUIRED BY HGGC EXHIBIT 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL ENTERS INTO A DEFINITIVE AGREEMENT TO BE ACQUIRED BY HGGC PARK CITY, Utah, May 22, 2017/PRNewswire/?Nutraceutical International Corporation (NASDAQ: NUTR) (?Nutraceutical? or the ?Company?) and HGGC, LLC (?HGGC?), a leading middle-market private eq |
|
| May 22, 2017 |
Frequently Asked Questions and Answers About Announced Pending Transaction with HGGC EXHIBIT 99.2 Frequently Asked Questions and Answers About Announced Pending Transaction with HGGC Nutraceutical International Corporation and its subsidiaries (?Nutraceutical? or the ?Company?) recently announced that it entered into an Agreement and Plan of Merger (the ?Merger Agreement?) with an affiliate of HGGC, LLC (?Buyer? or ?HGGC?). This communication is intended to address certain questio |
|
| May 22, 2017 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among NUTRITION PARENT, LLC, NUTRITION SUB, INC. and NUTRACEUTICAL INTERNATIONAL CORPORATION Dated as of May 21, 2017 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS & INTERPRETATIONS 2 1.1 Certain Definitions 2 1.2 Additional Definitions 14 1.3 Certain Interpretations 16 ARTICLE II THE MERGER 17 2.1 The Merger 17 2.2 The Effective Time 18 2.3 The Closi |
|
| May 22, 2017 |
Nutraceutical International 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 21, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of Incorporation) (Commission File Num |
|
| May 22, 2017 |
NUTRACEUTICAL ENTERS INTO A DEFINITIVE AGREEMENT TO BE ACQUIRED BY HGGC EXHIBIT 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL ENTERS INTO A DEFINITIVE AGREEMENT TO BE ACQUIRED BY HGGC PARK CITY, Utah, May 22, 2017/PRNewswire/?Nutraceutical International Corporation (NASDAQ: NUTR) (?Nutraceutical? or the ?Company?) and HGGC, LLC (?HGGC?), a leading middle-market private eq |
|
| April 27, 2017 |
NUTRACEUTICAL REPORTS FISCAL 2017 Q2 RESULTS Exhibit EXHIBIT 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2017 Q2 RESULTS PARK CITY, Utah, Apr 27, 2017/PRNewswire/-Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2017 second quarter ended March 31, 2017. Net sales for the fiscal 2017 se |
|
| April 27, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| April 27, 2017 |
Nutraceutical International 10-Q (Quarterly Report) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended March 31, 2017 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| April 19, 2017 |
Nutraceutical International ESP CORRESP 1 filename1.htm NUTRACEUTICAL INTERNATIONAL CORPORATION 1400 Kearns Boulevard, 2nd Floor Park City, Utah April 19, 2017 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Nutraceutical International Corporation Registration Statement on Form S-3 (File No. 333-216501) Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as am |
|
| April 6, 2017 |
NUTRACEUTICAL ANNOUNCES ACQUISITION Exhibit EXHIBIT 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL ANNOUNCES ACQUISITION PARK CITY, Utah, April 6, 2017/PRNewswire/-Nutraceutical International Corporation (NASDAQ: NUTR) today announced that it has acquired substantially all the assets associated with the Zhou Nutrition brand from Branson |
|
| April 6, 2017 |
Financial Statements and Exhibits, Other Events Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| March 31, 2017 |
letters3markup Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019-6064 March 31, 2017 Via EDGAR Suzanne Hayes Division of Corporation Finance Securities and Exchange Commission 100 F Street, NE Washington, D. |
|
| March 31, 2017 |
As filed with the Securities and Exchange Commission on March 31, 2017 Registration No. |
|
| March 7, 2017 |
Nutraceutical International S-3 Document As filed with the Securities and Exchange Commission on March 7, 2017 Registration No. |
|
| March 3, 2017 |
NUTRACEUTICAL ANNOUNCES QUARTERLY DIVIDEND Exhibit EXHIBIT 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL ANNOUNCES QUARTERLY DIVIDEND PARK CITY, Utah, Mar 3, 2017/PRNewswire/-Nutraceutical International Corporation (NASDAQ: NUTR) today announced that its Board of Directors has declared a quarterly cash dividend on Nutraceutical International C |
|
| March 3, 2017 |
Financial Statements and Exhibits, Other Events Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| February 15, 2017 |
SC 13G/A 1 frankwgayiischedule13g012.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 16*) Nutraceutical International Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 67060Y101 (CUSIP Number) February 25, 1998 (Date of Event Which Requires Fi |
|
| February 10, 2017 |
Schedule 13G Amendment No. 8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8)* Nutraceutical International Corp. (Name of Issuer) Common (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 9, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* NUTRACEUTICAL INTL CORP (Name of Issuer) Common Stock (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| January 26, 2017 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2017 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| January 26, 2017 |
NUTRACEUTICAL REPORTS FISCAL 2017 Q1 RESULTS EX-99.1 2 nutr-ex991x012617.htm EXHIBIT 99.1 EXHIBIT 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2017 Q1 RESULTS PARK CITY, Utah, Jan 26, 2017/PRNewswire/-Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2017 first quarter ended December 31, |
|
| January 26, 2017 |
Nutraceutical International 10-Q (Quarterly Report) 10-Q 1 nutr-123116x10q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended December 31, 2016 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of inco |
|
| December 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2016 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| December 16, 2016 |
EX-10.1 2 nutr-ex101x121616xpsux8k.htm EXHIBIT 10.1 EXHIBIT 10.1 NUTRACEUTICAL INTERNATIONAL CORPORATION 2013 LONG-TERM EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT GRANT NOTICE Nutraceutical International Corporation, a Delaware corporation (the “Company”), pursuant to the Nutraceutical International Corporation 2013 Long-Term Equity Incentive Plan (the “Plan”), hereby grants to the individual li |
|
| December 16, 2016 |
Nutraceutical International DEF 14A Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Pr |
|
| December 1, 2016 |
NUTRACEUTICAL ANNOUNCES QUARTERLY DIVIDEND Exhibit EXHIBIT 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL ANNOUNCES QUARTERLY DIVIDEND PARK CITY, Utah, Dec 1, 2016/PRNewswire/-Nutraceutical International Corporation (NASDAQ: NUTR) today announced that its Board of Directors has declared a quarterly cash dividend on Nutraceutical International C |
|
| December 1, 2016 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2016 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| November 17, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2016 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| November 17, 2016 |
NUTRACEUTICAL REPORTS FISCAL 2016 YEAR END RESULTS Exhibit EXHIBIT 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2016 YEAR END RESULTS PARK CITY, Utah, Nov 17, 2016/PRNewswire/-Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2016 fourth quarter ended September 30, 2016. Net sales for the fisc |
|
| November 17, 2016 |
Nutraceutical International 10-K (Annual Report) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPP ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Fiscal Year Ended September 30, 2016 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EX |
|
| November 17, 2016 |
EXHIBIT 21.1 SUBSIDIARIES OF NUTRACEUTICAL 3939 24th Street, Inc. (Delaware) All One, Inc. (Delaware) American Nutritional Casualty Insurance, Inc. (Hawaii) Au Naturel, Inc. (Delaware) Au Naturel (Canada), Inc. (Delaware) Au Naturel (Japan), Inc. (Delaware) Au Naturel (UK), Inc. (Delaware) Beehive Organics, Inc. (Delaware) Elephant Pharmacy, Inc. (Delaware) Fresh Stores, Inc. (Delaware) Fresh To Y |
|
| July 28, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2016 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| July 28, 2016 |
NUTRACEUTICAL REPORTS FISCAL 2016 Q3 RESULTS AND EXPANDS SHARE REPURCHASE PROGRAM EX-99.1 2 nutr-ex991x072816.htm EXHIBIT 99.1 EXHIBIT 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2016 Q3 RESULTS AND EXPANDS SHARE REPURCHASE PROGRAM PARK CITY, Utah, July 28, 2016/PRNewswire/-Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal |
|
| July 28, 2016 |
Nutraceutical International 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended June 30, 2016 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| April 28, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2016 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| April 28, 2016 |
NUTRACEUTICAL REPORTS FISCAL 2016 Q2 RESULTS EX-99.1 2 nutr-ex991x042816.htm EXHIBIT 99.1 EXHIBIT 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2016 Q2 RESULTS PARK CITY, Utah, April 28, 2016/PRNewswire/-Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2016 second quarter ended March 31, |
|
| April 28, 2016 |
Nutraceutical International 10-Q (Quarterly Report) 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended March 31, 2016 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| February 16, 2016 |
NUTR / Nutraceutical International Corp. / GAY FRANK W II - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 16*) Nutraceutical International Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 67060Y101 (CUSIP Number) February 25, 1998 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| February 11, 2016 |
SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7)* Nutraceutical International Corp. (Name of Issuer) Common (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| February 9, 2016 |
SC 13G/A 1 rrd384.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* NUTRACEUTICAL INTL CORP (Name of Issuer) Common Stock (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desi |
|
| January 28, 2016 |
NUTRACEUTICAL REPORTS FISCAL 2016 Q1 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2016 Q1 RESULTS PARK CITY, Utah, Jan 28, 2016/PRNewswire/?Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2016 first quarter ended December 31, 2015. Net sales for the fiscal 2016 first qu |
|
| January 28, 2016 |
Nutraceutical International 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2016 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| January 28, 2016 |
NUTR / Nutraceutical International Corp. 10-Q - Quarterly Report - 10-Q Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended December 31, 2015 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| December 18, 2015 |
Nutraceutical International DEF 14A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 19, 2015 |
NUTRACEUTICAL REPORTS FISCAL 2015 YEAR END RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2015 YEAR END RESULTS PARK CITY, Utah, Nov 19, 2015/PRNewswire/?Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2015 fourth quarter ended September 30, 2015. Net sales for the fiscal 2015 |
|
| November 19, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K 10-K 1 a2226535z10-k.htm 10-K Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Fiscal Year Ended September 30, 2015 or o TRANSITION REPORT PURSUANT TO SECTION 1 |
|
| November 19, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a15-2372418k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2015 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 ( |
|
| November 19, 2015 |
QuickLinks - Click here to rapidly navigate through this document EXHIBIT 21.1 SUBSIDIARIES OF NUTRACEUTICAL 3939 24th Street, Inc. (Delaware) All One, Inc. (Delaware) American Nutritional Casualty Insurance, Inc. (Hawaii) Au Naturel, Inc. (Delaware) Au Naturel (Canada), Inc. (Delaware) Au Naturel (Japan), Inc. (Delaware) Au Naturel (UK), Inc. (Delaware) Beehive Organics, Inc. (Delaware) Elephant |
|
| July 30, 2015 |
10-Q 1 a2225470z10-q.htm 10-Q Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended June 30, 2015 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION ( |
|
| July 30, 2015 |
NUTRACEUTICAL REPORTS FISCAL 2015 Q3 RESULTS EX-99.1 2 a15-165671ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2015 Q3 RESULTS PARK CITY, Utah, July 30, 2015/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2015 third quarter ended June 30, 2015. Ne |
|
| July 30, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2015 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| April 30, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a15-1033918k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2015 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorpor |
|
| April 30, 2015 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended March 31, 2015 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| April 30, 2015 |
NUTRACEUTICAL REPORTS FISCAL 2015 Q2 RESULTS EX-99.1 2 a15-103391ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2015 Q2 RESULTS PARK CITY, Utah, April 30, 2015/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2015 second quarter ended March 31, 2015. |
|
| February 13, 2015 |
NUTR / Nutraceutical International Corp. / GAY FRANK W II - SC 13G/A Passive Investment SC 13G/A 1 a15-45001sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 15*) Nutraceutical International Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 67060Y101 (CUSIP Number) February 25, 1998 (Date of Event Which Requires Filing of th |
|
| February 11, 2015 |
SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* Nutraceutical International Corp. (Name of Issuer) Common (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| February 5, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NUTRACEUTICAL INTL CORP (Name of Issuer) Common Stock (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| January 29, 2015 |
NUTRACEUTICAL REPORTS FISCAL 2015 Q1 RESULTS EX-99.1 2 a15-33391ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2015 Q1 RESULTS PARK CITY, Utah, January 29, 2015/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2015 first quarter ended December 31, 20 |
|
| January 29, 2015 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended December 31, 2014 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| January 29, 2015 |
8-K 1 a15-333918k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2015 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Co |
|
| December 19, 2014 |
NUTR / Nutraceutical International Corp. DEF 14A - - DEF 14A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 20, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2014 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 20, 2014 |
QuickLinks - Click here to rapidly navigate through this document EXHIBIT 21.1 SUBSIDIARIES OF NUTRACEUTICAL All One, Inc. (Delaware) American Nutritional Casualty Insurance, Inc. (Hawaii) Au Naturel, Inc. (Delaware) Au Naturel (Canada), Inc. (Delaware) Au Naturel (Japan), Inc. (Delaware) Au Naturel (UK), Inc. (Delaware) Beehive Organics, Inc. (Delaware) Elephant Pharmacy, Inc. (Delaware) Fresh Or |
|
| November 20, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Use these links to rapidly review the document TABLE OF CONTENTS Nutraceutical International Corporation Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 20, 2014 |
NUTRACEUTICAL REPORTS FISCAL 2014 YEAR END RESULTS EX-99.1 2 a14-248791ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2014 YEAR END RESULTS PARK CITY, Utah, November 20, 2014/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2014 fourth quarter ended Septem |
|
| November 5, 2014 |
NUTRACEUTICAL INCREASES CREDIT LINE EX-99.1 4 a14-237641ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL INCREASES CREDIT LINE PARK CITY, Utah, Nov 5, 2014/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) is pleased to announce that it has closed on an amended revolving credit facility, with Rab |
|
| November 5, 2014 |
EX-10.13 3 a14-237641ex10d13.htm EX-10.13 Exhibit 10.13 Annex I to Amendment Agreement AMENDED AND RESTATED CREDIT AGREEMENT among NUTRACEUTICAL INTERNATIONAL CORPORATION, NUTRACEUTICAL CORPORATION, VARIOUS LENDING INSTITUTIONS, COÖPERATIEVE CENTRALE RAIFFEISEN-BOERENLEENBANK B.A., “RABOBANK NEDERLAND”, NEW YORK BRANCH, as Administrative Agent, Co-Arranger, and Co-Bookrunner and WELLS FARGO BANK, |
|
| November 5, 2014 |
EX-10.12 2 a14-237641ex10d12.htm EX-10.12 Exhibit 10.12 SECOND AMENDMENT AGREEMENT This SECOND AMENDMENT AGREEMENT (this “Amendment”), is dated as of November 4, 2014, by and among NUTRACEUTICAL INTERNATIONAL CORPORATION, a Delaware corporation (“Holdings”), NUTRACEUTICAL CORPORATION, a Delaware corporation (the “Borrower”), the Banks (as defined below) signatory hereto, and COÖPERATIEVE CENTRALE |
|
| November 5, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2014 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 31, 2014 |
NUTRACEUTICAL REPORTS FISCAL 2014 Q3 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2014 Q3 RESULTS PARK CITY, Utah, July 31, 2014/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2014 third quarter ended June 30, 2014. Net sales for the fiscal 2014 third quart |
|
| July 31, 2014 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended June 30, 2014 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| July 31, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2014 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission (IRS Employer File Number) Identification No. |
|
| April 24, 2014 |
NUTRACEUTICAL REPORTS FISCAL 2014 Q2 RESULTS EX-99.1 2 a14-110541ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2014 Q2 RESULTS PARK CITY, Utah, April 24, 2014/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2014 second quarter ended March 31, 2014. |
|
| April 24, 2014 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended March 31, 2014 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| April 24, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2014 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 18, 2014 |
NUTR / Nutraceutical International Corp. / GAY FRANK W II - SC 13G/A Passive Investment SC 13G/A 1 a14-60941sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 14)* Nutraceutical International Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 67060Y101 (CUSIP Number) February 25, 1998 (Date of Event Which Requires Filing of th |
|
| February 10, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NUTRACEUTICAL INTL CORP (Name of Issuer) Common Stock (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| February 3, 2014 |
SC 13G/A 1 d665888dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* Nutraceutical International Corp. (Name of Issuer) Common (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box t |
|
| January 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2014 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| January 30, 2014 |
10-Q 1 a2218042z10-q.htm 10-Q Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended December 31, 2013 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATI |
|
| January 30, 2014 |
NUTRACEUTICAL REPORTS FISCAL 2014 Q1 RESULTS EX-99.1 2 a14-46701ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2014 Q1 RESULTS PARK CITY, Utah, January 30, 2014/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2014 first quarter ended December 31, 20 |
|
| December 23, 2013 |
DEF 14A 1 a2217731zdef14a.htm DEF 14A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary P |
|
| November 26, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 26, 2013 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| November 26, 2013 |
NUTRACEUTICAL REPORTS FISCAL 2013 YEAR END RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2013 YEAR END RESULTS PARK CITY, Utah, November 26, 2013/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2013 fourth quarter ended September 30, 2013. Net sales for the fiscal |
|
| November 26, 2013 |
QuickLinks - Click here to rapidly navigate through this document EXHIBIT 21.1 SUBSIDIARIES OF NUTRACEUTICAL All One, Inc. (Delaware) American Nutritional Casualty Insurance, Inc. (Hawaii) Au Naturel, Inc. (Delaware) Au Naturel (Canada), Inc. (Delaware) Au Naturel (Japan), Inc. (Delaware) Au Naturel (UK), Inc. (Delaware) Beehive Organics, Inc. (Delaware) Elephant Pharmacy, Inc. (Delaware) Fresh Or |
|
| November 26, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K 10-K 1 a2217320z10-k.htm 10-K Use these links to rapidly review the document TABLE OF CONTENTS Nutraceutical International Corporation Index to Consolidated Financial Statements Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Fiscal Year Ende |
|
| July 25, 2013 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended June 30, 2013 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| July 25, 2013 |
QuickLinks - Click here to rapidly navigate through this document Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF NUTRACEUTICAL INTERNATIONAL CORPORATION A Delaware Corporation ARTICLE I OFFICES Section 1. Registered Office. The registered office of Nutraceutical International Corporation (the "Corporation") in the State of Delaware shall be located at 1013 Centre Road, in the City of Wilmington, Coun |
|
| July 25, 2013 |
NUTRACEUTICAL REPORTS FISCAL 2013 Q3 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2013 Q3 RESULTS PARK CITY, Utah, July 25, 2013/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2013 third quarter ended June 30, 2013. Net sales for the fiscal 2013 third quart |
|
| July 25, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a13-1718918k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2013 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Comm |
|
| April 25, 2013 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended March 31, 2013 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| April 25, 2013 |
NUTRACEUTICAL REPORTS FISCAL 2013 Q2 RESULTS EX-99.1 2 a13-107701ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2013 Q2 RESULTS PARK CITY, Utah, April 25, 2013/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2013 second quarter ended March 31, 2013. |
|
| April 25, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2013 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| February 11, 2013 |
Schedule 13G Amendment No. 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Nutraceutical International Corp. (Name of Issuer) Common (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 7, 2013 |
NUTR / Nutraceutical International Corp. / GAY FRANK W II - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13)* Nutraceutical International Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 67060Y101 (CUSIP Number) February 25, 1998 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| January 31, 2013 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended December 31, 2012 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| January 31, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2013 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| January 31, 2013 |
EX-10.2 3 a13-40661ex10d2.htm EX-10.2 Exhibit 10.2 NUTRACEUTICAL INTERNATIONAL CORPORATION 2013 LONG-TERM EQUITY INCENTIVE PLAN NONQUALIFIED STOCK OPTION AGREEMENT THIS NONQUALIFIED STOCK OPTION AGREEMENT (the “Agreement”) is made by and between NUTRACEUTICAL INTERNATIONAL CORPORATION, a Delaware corporation (the “Company”), and you (the “Participant”), and is dated as of the date set forth on the |
|
| January 31, 2013 |
EX-10.4 5 a13-40661ex10d4.htm EX-10.4 Exhibit 10.4 NUTRACEUTICAL INTERNATIONAL CORPORATION 2013 LONG-TERM EQUITY INCENTIVE PLAN NONQUALIFIED STOCK OPTION AGREEMENT THIS NONQUALIFIED STOCK OPTION AGREEMENT (the “Agreement”) is made by and between NUTRACEUTICAL INTERNATIONAL CORPORATION, a Delaware corporation (the “Company”), and you (the “Participant”), and is dated as of the date set forth on the |
|
| January 31, 2013 |
EX-10.5 6 a13-40661ex10d5.htm EX-10.5 Exhibit 10.5 NUTRACEUTICAL INTERNATIONAL CORPORATION 2013 LONG-TERM EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT THIS RESTRICTED STOCK AWARD AGREEMENT (the “Agreement”) is made by and between NUTRACEUTICAL INTERNATIONAL CORPORATION, a Delaware corporation (the “Company”), and you (the “Participant”), and is dated as of the date set forth on the signa |
|
| January 31, 2013 |
S-8 1 a13-40441s8.htm S-8 As filed with the Securities and Exchange Commission on January 31, 2013 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction |
|
| January 31, 2013 |
Nutraceutical International Corporation 2013 Long-Term Equity Incentive Plan EX-10.1 2 a13-40661ex10d1.htm EX-10.1 Exhibit 10.1 Nutraceutical International Corporation 2013 Long-Term Equity Incentive Plan 1. Purpose. The purpose of the Nutraceutical International Corporation 2013 Long-Term Equity Incentive Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel, including the services of experienced and knowledgeable non |
|
| January 31, 2013 |
NUTRACEUTICAL REPORTS FISCAL 2013 Q1 RESULTS EX-99.1 7 a13-40661ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2013 Q1 RESULTS PARK CITY, Utah, Jan 31, 2013/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2013 first quarter ended December 31, 201 |
|
| January 31, 2013 |
EX-10.3 4 a13-40661ex10d3.htm EX-10.3 Exhibit 10.3 NUTRACEUTICAL INTERNATIONAL CORPORATION 2013 LONG-TERM EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT THIS RESTRICTED STOCK AWARD AGREEMENT (the “Agreement”) is made by and between NUTRACEUTICAL INTERNATIONAL CORPORATION, a Delaware corporation (the “Company”), and you (the “Participant”), and is dated as of the date set forth on the signa |
|
| December 21, 2012 |
DEF 14A 1 a2212244zdef14a.htm DEF 14A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary P |
|
| December 12, 2012 |
NUTRACEUTICAL ANNOUNCES SPECIAL DIVIDEND EX-99.1 2 a12-292031ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL ANNOUNCES SPECIAL DIVIDEND PARK CITY, Utah, December 11, 2012/PR Newswire. Nutraceutical International Corporation (NASDAQ: NUTR) today announced that its Board of Directors has declared a first ever, speci |
|
| December 12, 2012 |
Financial Statements and Exhibits, Other Events 8-K 1 a12-2920318k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2012 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incor |
|
| November 21, 2012 |
QuickLinks - Click here to rapidly navigate through this document EXHIBIT 21.1 SUBSIDIARIES OF NUTRACEUTICAL All One, Inc. (Delaware) American Nutritional Casualty Insurance, Inc. (Hawaii) Au Naturel, Inc. (Delaware) Au Naturel (Canada), Inc. (Delaware) Au Naturel (Japan), Inc. (Delaware) Au Naturel (UK), Inc. (Delaware) Beehive Organics, Inc. (Delaware) Elephant Pharmacy, Inc. (Delaware) Fresh Or |
|
| November 21, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2012 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 21, 2012 |
NUTRACEUTICAL REPORTS FISCAL 2012 YEAR END RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2012 YEAR END RESULTS PARK CITY, Utah, Nov 20, 2012/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2012 fourth quarter ended September 30, 2012. Net sales for the fiscal 2012 |
|
| November 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Use these links to rapidly review the document TABLE OF CONTENTS Nutraceutical International Corporation Index to Consolidated Financial Statements Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 26, 2012 |
NUTRACEUTICAL REPORTS FISCAL 2012 Q3 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2012 Q3 RESULTS PARK CITY, Utah, July 26, 2012/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2012 third quarter ended June 30, 2012. Net sales for the fiscal 2012 third quart |
|
| July 26, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2012 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| July 26, 2012 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended June 30, 2012 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| April 26, 2012 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended March 31, 2012 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 87-0515089 (State of incorporation) (IRS Employer Identification No. |
|
| April 26, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a12-786538k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2012 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorpora |
|
| April 26, 2012 |
NUTRACEUTICAL REPORTS FISCAL 2012 Q2 RESULTS AND EXPANDS SHARE REPURCHASE PROGRAM Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2012 Q2 RESULTS AND EXPANDS SHARE REPURCHASE PROGRAM PARK CITY, Utah, Apr 26/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2012 second quarter ended March 31, 2012. Net sales |
|
| February 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Nutraceutical International Corp. (Name of issuer) Common (Title of class of securities) 67060Y101 (CUSIP number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| February 10, 2012 |
Schedule 13G Amendment No. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Nutraceutical International Corp. (Name of issuer) Common (Title of class of securities) 67060Y101 (CUSIP number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 7, 2012 |
NUTR / Nutraceutical International Corp. / GAY FRANK W II - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12*) Nutraceutical International Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 67060Y101 (CUSIP Number) February 25, 1998 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| January 26, 2012 |
8-K 1 a12-211938k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2012 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Co |
|
| January 26, 2012 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended December 31, 2011 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| January 26, 2012 |
NUTRACEUTICAL REPORTS FISCAL 2012 Q1 RESULTS EX-99.1 2 a12-21193ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2012 Q1 RESULTS PARK CITY, Utah, Jan 26/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2012 first quarter ended December 31, 2011. Net sa |
|
| January 12, 2012 |
DEFA14A 1 a12-26451defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as |
|
| December 22, 2011 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 19, 2011 |
QuickLinks - Click here to rapidly navigate through this document EXHIBIT 21.1 SUBSIDIARIES OF NUTRACEUTICAL American Nutritional Casualty Insurance, Inc. (Hawaii) All One, Inc. (Delaware) Au Naturel, Inc. (Delaware) Au Naturel (Canada), Inc. (Delaware) Au Naturel (Japan), Inc. (Delaware) Au Naturel (UK), Inc. (Delaware) Beehive Organics, Inc. (Delaware) Elephant Pharmacy, Inc. (Delaware) Fresh Or |
|
| December 19, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Use these links to rapidly review the document TABLE OF CONTENTS Nutraceutical International Corporation Index to Consolidated Financial Statements Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 19, 2011 |
NUTRACEUTICAL REPORTS FISCAL 2011 YEAR END RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2011 YEAR END RESULTS PARK CITY, Utah, Dec 19/PRNewswire/?Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2011 fourth quarter and year ended September 30, 2011. Net sales for the fiscal 20 |
|
| December 19, 2011 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2011 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| December 15, 2011 |
NT 10-K 1 a11-266503nt10k.htm NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-23731 CUSIP NUMBER NOTIFICATION OF LATE FILING (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transit |
|
| July 28, 2011 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended June 30, 2011 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 87-0515089 (State of incorporation) (IRS Employer Identification No. |
|
| July 28, 2011 |
NUTRACEUTICAL REPORTS FISCAL 2011 Q3 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2011 Q3 RESULTS PARK CITY, Utah, Jul 28/PRNewswire/?Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2011 third quarter ended June 30, 2011. Net sales for the fiscal 2011 third quarter w |
|
| July 28, 2011 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2011 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| July 5, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Nutraceutical International Corp. (Name of Issuer) Common (Title of Class of Securities) 67060Y101 (CUSIP Number) June 30, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| April 28, 2011 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2011 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| April 28, 2011 |
NUTRACEUTICAL REPORTS FISCAL 2011 Q2 RESULTS EX-99.1 2 a11-106913ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2011 Q2 RESULTS PARK CITY, Utah, Apr 28/PRNewswire/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2011 second quarter ended March 31, 2011. Net |
|
| April 28, 2011 |
Use these links to rapidly review the document Table of Contents Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended March 31, 2011 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 87-0515089 (State of incorporation) (IRS Employer Identification No. |
|
| February 18, 2011 |
SC 13G/A 1 a11-62861sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11*) Nutraceutical International Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 67060Y101 (CUSIP Number) February 25, 1998 (Date of Event Which Requires Filing of th |
|
| February 11, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NUTRACEUTICAL INTL CORP (Name of Issuer) Common Stock (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| January 31, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Nutraceutical Intl Corp. (Name of Issuer) Common (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| January 27, 2011 |
NUTRACEUTICAL REPORTS FISCAL 2011 Q1 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2011 Q1 RESULTS PARK CITY, Utah, Jan 27/PRNewswire-First Call/?Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2011 first quarter ended December 31, 2010. Net sales for the fiscal 2011 |
|
| January 27, 2011 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2011 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| January 27, 2011 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended December 31, 2010 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 87-0515089 (State of incorporation) (IRS Employer Identification No. |
|
| January 25, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. 1)* Nutraceutical International Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 67060Y101 ( |
|
| January 21, 2011 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2011 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| December 22, 2010 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 21, 2010 |
NUTRACEUTICAL INCREASES CREDIT LINE Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL INCREASES CREDIT LINE PARK CITY, Utah, Dec 21/PRNewswire-First Call/?Nutraceutical International Corporation (NASDAQ: NUTR) has amended and restated its original January 2002 revolving credit facility agreement. Rabobank International will conti |
|
| December 21, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2010 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| December 21, 2010 |
EX-10.6 2 a10-211264ex10d6.htm EX-10.6 Exhibit 10.6 AMENDED AND RESTATED CREDIT AGREEMENT among NUTRACEUTICAL INTERNATIONAL CORPORATION, NUTRACEUTICAL CORPORATION, VARIOUS LENDING INSTITUTIONS, COÖPERATIEVE CENTRALE RAIFFEISEN-BOERENLEENBANK B.A., “RABOBANK NEDERLAND”, NEW YORK BRANCH, as Administrative Agent, Co-Arranger, and Co-Bookrunner and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicatio |
|
| November 23, 2010 |
QuickLinks - Click here to rapidly navigate through this document EXHIBIT 21.1 SUBSIDIARIES OF NUTRACEUTICAL American Nutritional Casualty Insurance, Inc. (Hawaii) Au Naturel, Inc. (Delaware) Au Naturel (Canada), Inc. (Delaware) Au Naturel (Japan), Inc. (Delaware) Au Naturel (UK), Inc. (Delaware) Beehive Organics, Inc. (Delaware) Elephant Pharmacy, Inc. (Delaware) Fresh Organics, Inc. (Delaware) F |
|
| November 23, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 23, 2010 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| November 23, 2010 |
NUTRACEUTICAL REPORTS FISCAL 2010 YEAR END RESULTS EX-99.1 2 a10-216821ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2010 YEAR END RESULTS PARK CITY, Utah, Nov 23/PRNewswire-First Call/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2010 fourth quarter and year |
|
| November 23, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Use these links to rapidly review the document TABLE OF CONTENTS Nutraceutical International Corporation Index to Consolidated Financial Statements Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 29, 2010 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended June 30, 2010 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| July 29, 2010 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2010 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| July 29, 2010 |
NUTRACEUTICAL REPORTS FISCAL 2010 Q3 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2010 Q3 RESULTS PARK CITY, Utah, July 29/PRNewswire-First Call/?Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2010 third quarter ended June 30, 2010. Net sales for the fiscal 2010 third |
|
| April 29, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2010 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| April 29, 2010 |
NUTRACEUTICAL REPORTS FISCAL 2010 Q2 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2010 Q2 RESULTS PARK CITY, Utah, Apr 29/PRNewswire-First Call/?Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2010 second quarter ended March 31, 2010. Net sales for the fiscal 2010 se |
|
| April 29, 2010 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended March 31, 2010 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| April 21, 2010 |
April 21, 2010 Jeffrey Riedler Assistant Director United States Securities and Exchange Commission 100 F Street N. |
|
| March 12, 2010 |
March 12, 2010 Jeffrey Riedler Assistant Director United States Securities and Exchange Commission 100 F Street N. |
|
| February 10, 2010 |
SC 13G 1 dsc13g.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Nutraceutical Intl Corp. (Name of Issuer) Common (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 8, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NUTRACEUTICAL INTL CORP (Name of Issuer) Common Stock (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| February 8, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10*) Nutraceutical International Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 67060Y101 (CUSIP Number) February 25, 1998 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| January 28, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2010 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| January 28, 2010 |
NUTRACEUTICAL REPORTS FISCAL 2010 Q1 RESULTS EX-99.1 2 a10-22132ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2010 Q1 RESULTS PARK CITY, Utah, Jan 28/PRNewswire-First Call/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2010 first quarter ended December 31 |
|
| January 28, 2010 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended December 31, 2009 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| January 8, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| January 8, 2010 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 10, 2009 |
QuickLinks - Click here to rapidly navigate through this document EXHIBIT 21.1 SUBSIDIARIES OF NUTRACEUTICAL American Nutritional Casualty Insurance, Inc. (Hawaii) Au Naturel, Inc. (Delaware) Au Naturel (Canada), Inc. (Delaware) Au Naturel (Japan), Inc. (Delaware) Au Naturel (Netherlands), Inc. (Delaware) Au Naturel (UK), Inc. (Delaware) Fresh Organics, Inc. (Delaware) Fresh To You, Inc. (Delaware |
|
| December 10, 2009 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2009 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| December 10, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Use these links to rapidly review the document TABLE OF CONTENTS Nutraceutical International Corporation Index to Consolidated Financial Statements Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 10, 2009 |
NUTRACEUTICAL REPORTS FISCAL 2009 YEAR END RESULTS EX-99.1 2 a09-346453ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2009 YEAR END RESULTS PARK CITY, Utah, Dec. 10/PRNewswire-First Call/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2009 fourth quarter and year |
|
| August 20, 2009 |
NUTRACEUTICAL ISSUES STATEMENT REGARDING PROPOSAL FROM RYAN DREXLER Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL ISSUES STATEMENT REGARDING PROPOSAL FROM RYAN DREXLER PARK CITY, Utah (August 20, 2009)?Nutraceutical International Corporation (NASDAQ: NUTR) acknowledges receipt from Mr. Ryan Drexler of an unsolicited letter dated August 18, 2009, outlining a |
|
| August 20, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2009 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission (IRS Employer File Number) Identification No. |
|
| July 30, 2009 |
NUTRACEUTICAL REPORTS FISCAL 2009 Q3 RESULTS AND EXPANDS SHARE REPURCHASE PROGRAM EX-99.1 2 a09-184322ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2009 Q3 RESULTS AND EXPANDS SHARE REPURCHASE PROGRAM PARK CITY, Utah, July 30/PRNewswire-First Call/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fisc |
|
| July 30, 2009 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2009 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| July 30, 2009 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended June 30, 2009 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| April 30, 2009 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2009 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission (IRS Employer File Number) Identification No. |
|
| April 30, 2009 |
NUTRACEUTICAL REPORTS FISCAL 2009 Q2 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2009 Q2 RESULTS PARK CITY, Utah, April 30/PRNewswire-First Call/?Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2009 second quarter ended March 31, 2009. Net sales for the fiscal 2009 |
|
| April 30, 2009 |
Table of Contents SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended March 31, 2009 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| February 17, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. )* Nutraceutical International Corporation (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 67060Y101 (CUSIP Number) |
|
| February 12, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Nutraceutical Intl Corp. (Name of Issuer) Common (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2008 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 11, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9*) Nutraceutical International Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 67060Y101 (CUSIP Number) February 25, 1998 (Date of Event Which Requires Filing of this Statement) Check the appropriate box t |
|
| January 29, 2009 |
FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION EX-99.1 2 a09-36612ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2009 Q1 RESULTS PARK CITY, Utah, January 29/PRNewswire-First Call/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2009 first quarter ended December 3 |
|
| January 29, 2009 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended December 31, 2008 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 87-0515089 (State of incorporation) (IRS Employer Identification No. |
|
| January 29, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2009 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission (IRS Employer File Number) Identification No. |
|
| December 19, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| December 19, 2008 |
Use these links to rapidly review the document Nutraceutical International Corporation TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 20, 2008 |
QuickLinks - Click here to rapidly navigate through this document EXHIBIT 21.1 SUBSIDIARIES OF NUTRACEUTICAL American Nutritional Casualty Insurance, Inc. (Hawaii) Au Naturel, Inc. (Delaware) Au Naturel (Canada), Inc. (Delaware) Au Naturel (Japan), Inc. (Delaware) Au Naturel (Netherlands), Inc. (Delaware) Au Naturel (UK), Inc. (Delaware) Fresh Organics, Inc. (Delaware) Fresh To You, Inc. (Delaware |
|
| November 20, 2008 |
Use these links to rapidly review the document TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 20, 2008 |
NUTRACEUTICAL REPORTS 2008 FISCAL YEAR END RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS 2008 FISCAL YEAR END RESULTS PARK CITY, Utah, November 20/PRNewswire-First Call/?Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sale |
|
| November 20, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2008 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 14, 2008 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2008 (October 13, 2008) NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 14, 2008 |
NUTRACEUTICAL TO PRESENT AT CANACCORD ADAMS HEALTHY LIVING CONFERENCE Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL TO PRESENT AT CANACCORD ADAMS HEALTHY LIVING CONFERENCE PARK CITY, Utah, October 13/PRNewswire/?Nutraceutical International Corporation (NASDAQ: NUTR) today announced that Bruce Hough, President, and Cory McQueen, Vice President and Chief Financ |
|
| July 31, 2008 |
NUTRACEUTICAL REPORTS Q3 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS Q3 RESULTS PARK CITY, Utah, July 31/PRNewswire-First Call/?Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2008 third quarter ended June 30, 2008. Net sales for the fiscal 2008 third quarter w |
|
| July 31, 2008 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended June 30, 2008 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 87-0515089 (State of incorporation) (IRS Employer Identification No. |
|
| July 31, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2008 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission (IRS Employer File Number) Identification No. |
|
| May 1, 2008 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2008 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 1, 2008 |
NUTRACEUTICAL REPORTS STRONGER Q2 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS STRONGER Q2 RESULTS PARK CITY, Utah, May 1/PRNewswire-First Call/?Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2008 second quarter ended March 31, 2008. Net sales for the fiscal 2008 second |
|
| May 1, 2008 |
Use these links to rapidly review the document INDEX UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the Quarterly Period Ended March 31, 2008 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| February 22, 2008 |
Jim B. Rosenberg Senior Assistant Chief Accountant United States Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Nutraceutical International Corporation Form 10-K for the Fiscal Year Ended September 30, 2007 Filed November 29, 2007 File No. 000-23731 Dear Mr. Rosenberg: We are in receipt of your comment letter dated February 4, 2008. Our responses, which follow the |
|
| February 12, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Nutraceutical Intl Corp. (Name of Issuer) Common (Title of Class of Securities) 67060Y101 (CUSIP Number) December 31, 2007 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 8, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8)* Nutraceutical International Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 67060Y101 (CUSIP Number) February 25, 1998 (Date of Event Which Requires Filing of this Statement) Check the appropriate box t |
|
| February 8, 2008 |
CORRESP 1 filename1.htm February 8, 2008 Jim B. Rosenberg Senior Assistant Chief Accountant United States Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Nutraceutical International Corporation Form 10-K for the Fiscal Year Ended September 30, 2007 Dear Mr. Rosenberg: We acknowledge receipt of your comment letter dated February 4, 2008. As per our discussion on Febr |
|
| January 31, 2008 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2008 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| January 31, 2008 |
Use these links to rapidly review the document INDEX SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2007 Commission file number 000-23731 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 87-0515089 (IRS Employer Identification No. |
|
| January 31, 2008 |
NUTRACEUTICAL REPORTS FISCAL 2008 Q1 RESULTS EX-99.1 2 a08-42611ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS FISCAL 2008 Q1 RESULTS PARK CITY, Utah, Jan 31/PRNewswire-First Call/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2008 first quarter ended December 31 |
|
| December 27, 2007 |
Use these links to rapidly review the document TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 26, 2007 |
Use these links to rapidly review the document TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 29, 2007 |
NUTRACEUTICAL REPORTS 2007 FISCAL YEAR END RESULTS EX-99.1 2 a07-303491ex99d1.htm EX-99.1 Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President, Finance and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS 2007 FISCAL YEAR END RESULTS PARK CITY, Utah, Nov 29/PRNewswire-First Call/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2007 fourth quarter |
|
| November 29, 2007 |
QuickLinks - Click here to rapidly navigate through this document EXHIBIT 21.1 SUBSIDIARIES OF NUTRACEUTICAL American Nutritional Casualty Insurance, Inc. (Hawaii) Au Naturel, Inc. (Delaware) Au Naturel (Canada), Inc. (Delaware) Au Naturel (Japan), Inc. (Delaware) Au Naturel (Netherlands), Inc. (Delaware) Au Naturel (UK), Inc. (Delaware) Fresh Organics, Inc. (Delaware) Fresh To You, Inc. (Delaware |
|
| November 29, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Use these links to rapidly review the document TABLE OF CONTENTS Nutraceutical International Corporation Index to Consolidated Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 29, 2007 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2007 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-23731 87-0515089 (State of incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 22, 2007 |
As filed with the Securities and Exchange Commission on October 19, 2007 As filed with the Securities and Exchange Commission on October 19, 2007 Registration No. |
|
| July 26, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2007 NUTRACEUTICAL INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 000-23731 (Commission File Number) 87-0515089 (IRS Employer Identification No. |
|
| July 26, 2007 |
NUTRACEUTICAL REPORTS Q3 RESULTS Exhibit 99.1 FOR: NUTRACEUTICAL INTERNATIONAL CORPORATION CONTACT: Cory J. McQueen Vice President, Finance and Chief Financial Officer (435) 655-6106 NUTRACEUTICAL REPORTS Q3 RESULTS PARK CITY, Utah, Jul 26/PRNewswire-First Call/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2007 third quarter ended June 30, 2007. Net sales for the fiscal 2007 third q |
